Common Contracts

Alvotech and Advanz Pharma extend strategic partnership to commercialize five proposed biosimilars in Europe

Alvotech • May 24th, 2023 • Biological products, (no disgnostic substances)

• Company
  Alvotech
• Filed
  May 24th, 2023
• Industry
  Biological products, (no disgnostic substances)

- The agreement includes proposed biosimilars to Simponi® (golimumab), Entyvio® (vedolizumab) and three additional early-stage undisclosed biosimilar candidates

Alvotech and Advanz Pharma extend strategic partnership to commercialize five proposed biosimilars in Europe

May 24th, 2023

• Filed
  May 24th, 2023

The agreement includes proposed biosimilars to Simponi® (golimumab), Entyvio® (vedolizumab) and three additional early-stage undisclosed biosimilar candidates